{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:31:46Z","timestamp":1785432706491,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ygyno.2015.08.010","type":"journal-article","created":{"date-parts":[[2015,8,31]],"date-time":"2015-08-31T13:17:10Z","timestamp":1441027030000},"page":"345-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial\u2013mesenchymal transition of the peritoneum"],"prefix":"10.1016","volume":"139","author":[{"given":"Michihiko","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro J.","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Kanemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Terai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Ohmichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.08.010_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1525-1438.2005.15351.x","article-title":"Treatment goals in ovarian cancer","volume":"15","author":"Ozols","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2015.08.010_bb0015","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z","article-title":"Ovarian carcinoma diagnosis","volume":"89","author":"Goff","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2015.08.010_bb0020","first-page":"255","article-title":"Ovarian surface epithelium: biology, endocrinology, and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0025","first-page":"3830","article-title":"Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H","volume":"53","author":"Cannistra","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0030","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrd2530","article-title":"Drug development of MET inhibitors: targeting oncogene addiction and expedience","volume":"7","author":"Comoglio","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0035","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1525-1438.2005.00117.x","article-title":"Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance","volume":"15","author":"Ayhan","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2015.08.010_bb0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/35083116","article-title":"Pathway specificity for Met signaling","volume":"3","author":"Comoglio","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0045","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/cncr.11335","article-title":"Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors","volume":"97","author":"Ocal","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2015.08.010_bb0050","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ijc.20598","article-title":"C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2\/neu","volume":"113","author":"Lengyel","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.08.010_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.onc.1208181","article-title":"Enhanced growth of human met-expressing xenografts in a new strain of immunocompromised mice transgenic for human hepatocyte growth factor\/scatter factor","volume":"24","author":"Zhang","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2015.08.010_bb0060","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.yexcr.2004.06.002","article-title":"Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation","volume":"299","author":"Wong","year":"2004","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0065","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/0008-5472.CAN-06-1147","article-title":"c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion","volume":"67","author":"Sawada","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1097-0215(19970926)73:1<151::AID-IJC23>3.0.CO;2-I","article-title":"Hepatocyte growth factor stimulates motility, chemotaxis, and mitogenesis in ovarian carcinoma cells expressing high levels of c-MET","volume":"73","author":"Corps","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.08.010_bb0075","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ijc.2910580507","article-title":"Overexpression of the MET\/HGF receptor in ovarian cancer","volume":"58","author":"DiRenzo","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.08.010_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1593\/neo.09948","article-title":"An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis","volume":"12","author":"Zillhardt","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.ygyno.2015.08.010_bb0085","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1071-5576(99)00040-4","article-title":"Characteristics and growth patterns of human peritoneal mesothelial cells: comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources","volume":"6","author":"Zhang","year":"1999","journal-title":"J. Soc. Gynecol. Investig."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/039139880502800213","article-title":"Effects of rapamycin on the epithelial-to-mesenchymal transition of human peritoneal mesothelial cells","volume":"28","author":"Aguilera","year":"2005","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.ygyno.2015.08.010_bb0095","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1152\/ajpendo.00573.2014","article-title":"Estradiol-mediated hepatocyte growth factor is involved in the implantation of endometriotic cells via the mesothelial\u2013mesenchymal transition in the peritoneum","volume":"308","author":"Ono","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1757-2215-7-38","article-title":"Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer","volume":"7","author":"Kawaguchi","year":"2014","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0105","first-page":"29","article-title":"Epidermal growth factor receptor expression in oligodendroglial tumors","volume":"149","author":"Reifenberger","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0110","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1525-1438.2007.01035.x","article-title":"A randomized study of screening for ovarian cancer: a multicenter study in Japan","volume":"18","author":"Kobayashi","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2015.08.010_bb0115","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.4281","article-title":"Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis","volume":"231","author":"Sandoval","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa020809","article-title":"Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells","volume":"348","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0125","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/molehr\/2.1.40","article-title":"Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells","volume":"2","author":"Arici","year":"1996","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0130","first-page":"2991","article-title":"Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture","volume":"44","author":"LaRocca","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1158\/2159-8290.CD-11-0117","article-title":"The first line of abdominal metastatic attack: breaching the mesothelial cell layer","volume":"1","author":"Kenny","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0140","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1210\/en.2005-1404","article-title":"Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells","volume":"147","author":"Zhou","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygyno.2015.08.010_bb0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10555-007-9107-6","article-title":"The Met tyrosine kinase receptor in development and cancer","volume":"27","author":"Gentile","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0150","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1095\/biolreprod62.3.491","article-title":"Expression and action of hepatocyte growth factor in human and bovine normal ovarian surface epithelium and ovarian cancer","volume":"62","author":"Parrott","year":"2000","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.ygyno.2015.08.010_bb0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1447-0756.2011.01695.x","article-title":"Alteration of HGF and TSP-1 expression in ovarian carcinoma associated with clinical features","volume":"38","author":"Wei","year":"2012","journal-title":"J. Obstet. Gynaecol. Res."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T21:16:28Z","timestamp":1567113388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815301025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0090825815301025"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.08.010","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial\u2013mesenchymal transition of the peritoneum","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}